Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Dermatology

  Free Subscription


22.06.2026

12 Am J Dermatopathol
1 Ann Intern Med
3 BMC Cancer
4 Br J Dermatol
2 Cancer
2 Cancer Lett
2 Cancer Res
5 Clin Exp Dermatol
1 Hum Mutat
1 Int J Dermatol
3 Intern Med
2 J Cutan Pathol
2 J Dermatol
5 J Invest Dermatol
1 Mycoses
1 Plast Reconstr Surg
11 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. STEGURA C, Steevens N, Neimy H, Saravanan S, et al
    Assessing Nuclear and Nucleolar Areas Between Malignant Melanoma and Benign Nevi.
    Am J Dermatopathol. 2026 Jun 18. doi: 10.1097/DAD.0000000000003355.
    PubMed         Abstract available

  2. LOMBARDO J, Pate HF, Grider DJ
    Widespread Symmetrical and Papular Lichenoid Eruption: Answer.
    Am J Dermatopathol. 2026;48:560-561.
    PubMed        

  3. DUPERRIER-RUIZ N, Haro-Ramos R, Arean-Cuns C, Mendoza-Cembranos MD, et al
    Nodular Granulomatous Phlebitis: A Case Report and Literature Review.
    Am J Dermatopathol. 2026;48:548-550.
    PubMed         Abstract available

  4. MAVERAKIS RAMIREZ N, Jaeger ZJ, Hinds BR
    "Osteoid" Syringoma: A Report of Two Cases of Cutaneous Mixed Tumor With Extensive Ossification and Review of the Literature.
    Am J Dermatopathol. 2026;48:529-532.
    PubMed         Abstract available

  5. FORTAREZZA F, Gnesotto L, Fiore PD, Tropea S, et al
    Clinicopathologic Features and Treatment Outcomes of Squamoid Eccrine Ductal Carcinoma: A Comprehensive Retrospective Series.
    Am J Dermatopathol. 2026;48:515-521.
    PubMed         Abstract available

  6. RATNAYAKE P, Udagedara C, Walisinghe D, Ranawaka A, et al
    Hypopigmented CD8 + Mycosis Fungoides in Sri Lanka: Clinicopathologic Evidence for an Indolent Variant.
    Am J Dermatopathol. 2026;48:522-525.
    PubMed         Abstract available

  7. GUNGOR SAHIN G, Eroglu E, Buyukbabani N, Ozturk Sari S, et al
    Comprehensive Immunohistochemical Analysis of Atypical Fibroxanthoma: Focus on PRAME in Differential Diagnosis.
    Am J Dermatopathol. 2026;48:509-514.
    PubMed         Abstract available

  8. D'ANGELO CV, Kimball KM, Franklin MJ
    An Unusual Case of Drug-Induced Hypersensitivity Syndrome With Multiple Atypical Histopathologic Findings.
    Am J Dermatopathol. 2026;48:545-547.
    PubMed         Abstract available

  9. OZCELIK EE, Sahin AB, Deligonul A, Balaban Adim S, et al
    Pilomatrix Carcinoma in a Hodgkin Lymphoma Survivor: A Rare Second Primary Tumor.
    Am J Dermatopathol. 2026;48:542-544.
    PubMed         Abstract available

  10. MERCADO-EVANS V, Levett K, Diwan AH, Huttenbach Y, et al
    Radiation-Induced Angiosarcoma of the Breast With Diffuse GATA-3 Positivity: A Possible Diagnostic Pitfall.
    Am J Dermatopathol. 2026;48:539-541.
    PubMed         Abstract available

  11. TOMINAGA M, Horiguchi SI, Nishizawa A, Goto K, et al
    Syringomatous Tumor Originating From an Axillary Supernumerary Mammary Tissue: First Report of an Axillary Tumor Case.
    Am J Dermatopathol. 2026;48:551-555.
    PubMed         Abstract available

  12. LOMBARDO J, Pate HF, Grider DJ
    Widespread Symmetrical and Papular Lichenoid Eruption: Challenge.
    Am J Dermatopathol. 2026;48:e61-e62.
    PubMed        


    Ann Intern Med

  13. QASEEM A, Harrod CS, Balk EM, Etxeandia-Ikobaltzeta I, et al
    Screening for Breast Cancer in Asymptomatic, Average-Risk Adult Females: A Guidance Statement From the American College of Physicians (Version 2).
    Ann Intern Med. 2026;179:842-856.
    PubMed         Abstract available


    BMC Cancer

  14. WU CY, Chung MH
    Factors associated with readmission following reconstruction in head and neck skin cancer: a national readmission database analysis.
    BMC Cancer. 2026 Jun 13. doi: 10.1186/s12885-026-16350.
    PubMed         Abstract available

  15. GUO J, Cui Y, Zhang N, Liang J, et al
    Integrated molecular pathology and therapeutic outcomes in dermatofibrosarcoma protuberans: Ki-67, COL1A1::PDGFB, and efficacy of Mohs surgery with postoperative imatinib in 153 Chinese patients.
    BMC Cancer. 2026;26:755.
    PubMed         Abstract available

  16. ANDREOU M, Chojnowska K, Filipowicz N, Horbacz M, et al
    Beyond tumors: uninvolved breast tissue of breast cancer patients with adverse prognoses is enriched for pathogenic PIK3CA and TP53 post-zygotic variants.
    BMC Cancer. 2026 Apr 30. doi: 10.1186/s12885-026-16086.
    PubMed         Abstract available


    Br J Dermatol

  17. XIA J, Kuzyakov Y, Krutmann J
    Microbial diversity as a proxy for skin health: an ecological framework misapplied.
    Br J Dermatol. 2026 Jun 17:ljag251. doi: 10.1093.
    PubMed        

  18. CHENG HC, Cheng JB, Cho RJ, McGrath JA, et al
    Dermatopathology in 4D: in situ spatial transcriptomics maps the cellular and molecular architecture of skin.
    Br J Dermatol. 2026 Jun 15:ljag246. doi: 10.1093.
    PubMed        

  19. DEMIREL S, McPherson T, Rajan N, Affleck A, et al
    When less is more: The role of dermatologists in promoting societal and self-acceptance of skin health and disease.
    Br J Dermatol. 2026 Jun 13:ljag239. doi: 10.1093.
    PubMed        

  20. CHEUNG S, Wang H, Wu J, Zhang L, et al
    Insulin resistance in psoriasis: metabolic recalibration and therapeutic prediction; a prospective cohort study at a tertiary referral centre.
    Br J Dermatol. 2026 Jun 12:ljag198. doi: 10.1093.
    PubMed        


    Cancer

  21. ARTESE AL, Zhou X, Small BJ, Ahles TA, et al
    Examining bidirectional longitudinal relationships between physical activity and physical function in older breast cancer survivors: The Thinking and Living with Cancer study.
    Cancer. 2026;132:e70366.
    PubMed         Abstract available

  22. LAWRENCE L
    No RFS benefit found from adding vibostolimab to pembrolizumab in patients with high-risk melanoma: Adding the anti-TIGIT antibody vibostolimab to adjuvant pembrolizumab failed to improve recurrence-free survival and increased toxicity.
    Cancer. 2026;132:e70439.
    PubMed        


    Cancer Lett

  23. ROY A, Ghosh A, Bhoumick A, Paul S, et al
    Thrombin-PAR1 signaling regulates Topoisomerase 1 activity to bridge inflammation and breast cancer progression.
    Cancer Lett. 2026;655:218646.
    PubMed         Abstract available

  24. ZHAO Z, Zheng ZY, Lei JT, Baik MJ, et al
    NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis.
    Cancer Lett. 2026;655:218636.
    PubMed         Abstract available


    Cancer Res

  25. HOU X, Chen M, Guo X, Xie Y, et al
    The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment That Drives Tumor Radioresistance.
    Cancer Res. 2026;86:3005-3025.
    PubMed         Abstract available

  26. AMBROSINI G, Do C, Tycko B, Realubit RB, et al
    Editor's Note: Inhibition of NF-kappaB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma.
    Cancer Res. 2026;86:3092.
    PubMed        


    Clin Exp Dermatol

  27. FARQUHAR K, Tweddell R
    Beyond Diagnosis: Expanding Scabies Education to Include Longitudinal Management, Atypical Presentations, Skin of Colour and Novel Diagnostic Techniques.
    Clin Exp Dermatol. 2026 Jun 17:llag250. doi: 10.1093.
    PubMed        

  28. SHEN Y, Huang J, Gao L, Sun Y, et al
    Paradoxical Worsening of Eczematous Cutaneous Immune-Related Adverse Events Associated with Dupilumab: Two Cases.
    Clin Exp Dermatol. 2026 Jun 17:llag249. doi: 10.1093.
    PubMed        

  29. ADVANI S, Raja A, Giraldo T, Aktas S, et al
    Efficacy and Safety of Icotrokinra for Plaque Psoriasis: A Systematic Review and Meta-analysis.
    Clin Exp Dermatol. 2026 Jun 17:llag255. doi: 10.1093.
    PubMed         Abstract available

  30. ZHANG Q, Meng Z, Zou Y
    Comment on 'Nail matrix melanoma in adolescents and young adults: a retrospective dermoscopic study': Do observations justify revision of diagnostic criteria?
    Clin Exp Dermatol. 2026 Jun 17:llag257. doi: 10.1093.
    PubMed        

  31. XIAO Y, Dong W, Zhu Y
    Comment on 'Cardiac involvement in severe cutaneous adverse reactions: a Retrospective Observational Cohort Study of DRESS and SJS/TEN at a major Australian tertiary hospital': towards precise definitions, phenotyping, and long-term follow-up.
    Clin Exp Dermatol. 2026 Jun 19:llag258. doi: 10.1093.
    PubMed        


    Hum Mutat

  32. YU Y, Wang M, Zhao B
    A Macrophage/Monocyte-Related Four-Gene Signature for Prognostic Assessment of Uveal Melanoma: BTBD6, C2CD4B, CCL24, and S100A4.
    Hum Mutat. 2026;2026:4978880.
    PubMed         Abstract available


    Int J Dermatol

  33. SRIVATSA A, Yaldo M, Cohn H, Rehman W, et al
    Dupilumab for the Treatment of Chronic Actinic Dermatitis: A Systematic Review.
    Int J Dermatol. 2026 Jun 13. doi: 10.1111/ijd.70542.
    PubMed        


    Intern Med

  34. INOMATA H, Asatani S, Ikumi N, Uchikawa M, et al
    Malignancy-associated Multicentric Reticulohistocytosis Mimicking Dermatomyositis-like Features, with a Significant Ultrasound Finding.
    Intern Med. 2025 Nov 6. doi: 10.2169/internalmedicine.6032.
    PubMed         Abstract available

  35. KOJIMA K, Takada J, Onishi S, Kubota M, et al
    Successful Dual Treatment of Crohn's Disease and Atopic Dermatitis with Upadacitinib: Two Case Reports.
    Intern Med. 2026 Jun 18. doi: 10.2169/internalmedicine.7661.
    PubMed         Abstract available

  36. OMI M, Akiyama M
    Kaposi's varicelliform eruption presenting with thick facial crusting.
    Intern Med. 2026 Jun 18. doi: 10.2169/internalmedicine.7228.
    PubMed        


    J Cutan Pathol

  37. NORDMANN M, Mazza T, Menzinger S, Kaya G, et al
    An Atypical Skin Presentation of Adult-Onset Still's Disease With Histological Description: A Case Report.
    J Cutan Pathol. 2026 Jun 18. doi: 10.1111/cup.70155.
    PubMed         Abstract available

  38. PHATCHARAMANEEPAKORN K, Sitthinamsuwan P, Pattanaprichakul P, Chairatchaneeboon M, et al
    Diagnostic Utility of PRAME Immunohistochemistry for Distinguishing Acral Melanoma From Acral Melanocytic Nevi.
    J Cutan Pathol. 2026 Jun 17. doi: 10.1111/cup.70163.
    PubMed         Abstract available


    J Dermatol

  39. CHANG CY, Li CY, Wang TH, Tsai CH, et al
    Recurrence Patterns and Prognostic Factors in Sentinel Lymph Node-Negative Melanoma in a Taiwanese Cohort With Predominant Acral Melanoma.
    J Dermatol. 2026 Jun 17. doi: 10.1111/1346-8138.70358.
    PubMed         Abstract available

  40. TAKIWAKI M, Kunimoto K, Nakatani Y, Miyazaki K, et al
    Analysis of Phosphorylated MEK1 Expression Pattern in Cutaneous Dilated Vessels of Capillary Malformations.
    J Dermatol. 2026 Jun 15. doi: 10.1111/1346-8138.70355.
    PubMed         Abstract available


    J Invest Dermatol

  41. RAYMUNDO JR, Senapati B, Zhu W, Lin AE, et al
    KCTD1/KCTD15 Complexes Repress AP-2alpha and AP-2beta to Regulate Neural Crest-Dependent Craniofacial Morphogenesis and Scalp Skin Development.
    J Invest Dermatol. 2026 Jun 12:S0022-202X(26)02600.
    PubMed         Abstract available

  42. KUNSTNER A, Abdelhamid A, Casetti F, Rodriguez E, et al
    Cutaneous dysbiosis in inherited ichthyoses/epidermal differentiation disorders: a prospective case-control study.
    J Invest Dermatol. 2026 Jun 13:S0022-202X(26)02603.
    PubMed        

  43. PARAGH G, Murakami M, Fitzgerald ME, Yan L, et al
    Topical 5-fluorouracil versus photodynamic therapy: differential impact on epidermal clonal mutations in early UV-induced skin carcinogenesis.
    J Invest Dermatol. 2026 Jun 15:S0022-202X(26)02608.
    PubMed        

  44. ZHOU T, Geng S
    Breaking the mast cell-T helper 2 axis in atopic dermatitis: Insights from oral MRGPRX2 antagonist.
    J Invest Dermatol. 2026 Jun 17:S0022-202X(26)01263.
    PubMed        

  45. LOUBNA O, Papouin B, Lamaison C, Ingen-Housz-Oro S, et al
    IL4I1+ Macrophage Accumulation in Advanced Cutaneous T-Cell Lymphomas Suggests a Role in Tumor Immune Escape.
    J Invest Dermatol. 2026 Jun 17:S0022-202X(26)02613.
    PubMed        


    Mycoses

  46. DURDU M, Kaplan E, Bingol O, Unal N, et al
    Comparison of DermaGenius and In-House qPCR Methods for Detection of Recalcitrant Dermatophyte Infections: A Practical Approach for Dermatologists and Mycologists.
    Mycoses. 2026;69:e70199.
    PubMed         Abstract available


    Plast Reconstr Surg

  47. KIM YC, Jang Y, Kim Y, Song HK, et al
    Therapeutic Potential of Bovine Colostrum-Derived Exosomes for Ischemia-Reperfusion Injury in Skin Flaps: A Rat Model Study.
    Plast Reconstr Surg. 2026 Jun 15. doi: 10.1097/PRS.0000000000013264.
    PubMed         Abstract available


    PLoS One

  48. KIM S, Zhang M, Ahn JK, Hwang J, et al
    Metabolite profiling of saliva for the discrimination of Behcet's disease, Sjogren's syndrome, and recurrent aphthous stomatitis.
    PLoS One. 2026;21:e0351403.
    PubMed         Abstract available

  49. ALAM R, Akter S, Mohammad T, Rini R, et al
    Knowledge of breast cancer and practice of breast self-examination among adolescent girls in semi-urban area - Savar, Dhaka, Bangladesh: A school-based cross-sectional study.
    PLoS One. 2026;21:e0334375.
    PubMed         Abstract available

  50. EKPO IA, Ovenseri AC, Abdullateef A, Durmaz B, et al
    Formulation of 5-fluorouracil loaded chitosan-based nanoparticles and evaluation of its cytotoxic effects against MCF-7 human breast cancer cells.
    PLoS One. 2026;21:e0350929.
    PubMed         Abstract available

  51. NDUKA IJ, Okafor CE, Ekwunife OI
    Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria.
    PLoS One. 2026;21:e0351492.
    PubMed         Abstract available

  52. LI Y, Haron A, Lin C, Tang Y, et al
    A scoping review of computational models of the diabetic foot.
    PLoS One. 2026;21:e0351638.
    PubMed         Abstract available

  53. XU H, Wu C, Zhang L, Ju Y, et al
    The effectiveness of a foot-care education program based on multi-theory model in diabetic patients with risk of foot ulceration: A randomized controlled trial protocol.
    PLoS One. 2026;21:e0350892.
    PubMed         Abstract available

  54. LIANAWATI, Laohasiriwong W, Htike KM, Thinkhamrop K, et al
    Survival analysis of time to amputation following diabetic foot ulcer diagnosis among Indonesians.
    PLoS One. 2026;21:e0343399.
    PubMed         Abstract available

  55. KOUAME JM, Kouakou C, Gnanou S, Yacouba B, et al
    Markov modeling in R: Advanced method using a cost-effectiveness analysis.
    PLoS One. 2026;21:e0350698.
    PubMed         Abstract available

  56. ZHENG LW, Liu YM, Yu KD, Liu CC, et al
    A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer.
    PLoS One. 2026;21:e0349410.
    PubMed         Abstract available

  57. WUTTITHANTAWEE Y, Wuttithantawee A, Wuttithantawee R, Pumpong P, et al
    Upregulation of RPLP1 in PBMCs as a screening biomarker for melanoma.
    PLoS One. 2026;21:e0350742.
    PubMed         Abstract available

  58. KHALIFA M, Soliman M, Omar A, Abouegylah M, et al
    Thyroid V40 as a potential early predictor of hypothyroidism following hypofractionated locoregional breast radiotherapy.
    PLoS One. 2026;21:e0351856.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  59. LAFIRENZE SJA, van Gerwen B, Quirindongo AI, Costermans N, et al
    Non-cell-autonomous mechanisms of tumor initiation and relapse by chromosomal instability.
    Proc Natl Acad Sci U S A. 2026;123:e2531095123.
    PubMed         Abstract available

  60. MISHRA A, Abelman RO, Cunneely Q, Putaturo V, et al
    Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.
    Proc Natl Acad Sci U S A. 2026;123:e2601563123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum